Abbott reviews

Abbott Molecular started off with great potential but I believe missed it's window of opportunity to be great. Senior Management is too removed from the day to day realities of what is needed to be successful and is not seriously open to real change beyond going through the motions. Too many people with too much of the Abbott Diagnostics approach to business in a rapidly evolving and very technical market that demands strategic thinking and innovation. There are way too many Directors that are simply checking off boxes demonstrating they accomplished a task without looking forward and backward to determine if the task was effective or not or coloring outside of the lines to approach things in a novel and more effective and strategic manner. Peter Principal is rampant at both Abbott Molecular and Abbott Diagnostics and will be very difficult to change. Innovation comes only through projects that are easy and drop in their laps while those that take risks and are innovative are often left to hang on their own with little support. Many training programs introduced each year that repeat similar topics from the prior year that were not followed up on but rather approached as a check off the box.

Very politically complicated, even at non-management levels Executive management too comfortable with status quo to encourage real change